Transfer of Sponsorship. Transfer is rarely permitted and is actively discouraged. Maintaining the integrity of sponsorship is absolutely mandatory for the success of the overall organization.
Transfer of Sponsorship. The parties acknowledge that Halliburton is designated as the sponsor with respect to the Halliburton NUS Corporation Employees’ Profit Sharing Plan (the “NUS Profit Sharing Plan”) and the Halliburton NUS Corporation Employees’ Pension Plan (the “NUS Pension Plan”), which plans provide benefits solely to KBR employees. On or before the Deconsolidation Date, Halliburton and KBR hereby agree to transfer the sponsorship of the NUS Profit Sharing Plan, the NUS Pension Plan and any other KBR Pension Plan (as applicable) from Halliburton to KBR. Furthermore, from and after the Deconsolidation Date, KBR shall have the sole obligation to provide to KBR Employees any benefits to which such employees are entitled under the NUS Profit Sharing Plan and the NUS Pension Plan, and Halliburton shall be relieved from all obligation or liability for the provision of such benefits to KBR Employees; provided, however, that to the extent any such benefits are funded in a trust maintained by Halliburton, such trust shall be divided between Halliburton and KBR as contemplated in Section 8.6 hereof.
Transfer of Sponsorship. Cydex shall promptly after the Effective Date send written notice as reasonably requested by Prism to the FDA transferring the sponsorship of the Registrations to Prism and Prism shall promptly after the Effective Date send written notice, as reasonably requested by CyDex or at its own discretion, to the FDA assuming all obligations thereunder, and such notices shall have an effective date that is approximately [***] days after the Effective Date (or such other date as may be agreed to by the Parties). CyDex shall reasonably assist Prism with the preparation and filing of all amendments to INDs, NDAs and orphan drug designations related to the Licensed Products. The Parties shall coordinate with one another and shall send such notices simultaneously, and each Party shall deliver a copy of its FDA notice to the other Party. CyDex shall promptly furnish to Prism the Registrations, to the extent not previously transferred, and the books and records relating thereto.
Transfer of Sponsorship. The Parties will cooperate to transfer sponsorship for any Clinical Trial and the IND which is a part of the ArQule Development Activities no later than ***. No later than ***, the Parties shall initiate discussions of the transfer, and shall develop and agree an operational plan for the transfer no later than ***, so that the transfer may timely occur no later than ***. In connection with the transfer of sponsorship, ArQule shall transfer all information Controlled by ArQule that is necessary to enable Basilea to act as sponsor, including but not limited to the Trial Master File (TMF). For the avoidance of doubt, from the Effective Date, Basilea shall be the sponsor of all Clinical Trials with respect to the Products in the Territory other than any Clinical Trial which is a part of the ArQule Development Activities.
Transfer of Sponsorship. 6.7.1 Transfer is rarely permitted and is actively discouraged. Maintaining the integrity of sponsorship is absolutely crucial for the success of the overall organization.
Transfer of Sponsorship. During the course of this agreement, the Sponsor may transfer its rights and obligations as Sponsor to a company formed by the Sponsor and in which the Sponsor has at least 40% ownership at the time of transfer, or another percent ownership interest agreed upon in writing by the Parties. Sponsor will notify the University and Principal Investigator in writing prior to any such transfer.
Transfer of Sponsorship. Although it is strongly discouraged and is seldom permitted, a Utopia Partner may transfer to a different Utopia Sponsor or Utopia Sponsorship line, subject to the written approval of the Company, which may be withheld in its sole discretion, subject to the following conditions:
Transfer of Sponsorship. Outlook shall within eight (8) business days after the date of FDA Approval send written notice to the FDA transferring the sponsorship of the ANDA to Auriga and Auriga shall at the same time send written notice to the FDA assuming all obligations thereunder, and such notices shall have an effective date that is approximately thirty (30) days after the date of FDA Approval. The parties shall coordinate with one another and shall send such notices simultaneously, and each party shall deliver a copy of its FDA notice to the other party.
Transfer of Sponsorship. Transfer of sponsorship will only be granted if appropriately applied for and approved by the Company. The Company may withhold, in its sole discretion, approval for any transfer of sponsorship for any reason. Transfer of sponsorship is highly discouraged and requires the following:
Transfer of Sponsorship. A Distributor who wishes to re-register under a new line of Sponsorship will need to be inactive for a period of three months. The Distributor must provide written notification to Home Office and the up-line Sponsor of his/her intention to cease trading as a Distributor. To be effective such notification must be accepted by Vita-Vida and the up-line Sponsor.
